Language: BG BG
← Back to results
Recruiting NCT06890078

Optimizing the Diagnosis of Pneumocystis in Immunocompromised Patients

Conditions: Pneumocystis Immunocompromised Patients

Sponsor: Assistance Publique - Hôpitaux de Paris

trial.available_in: БГ
Overview
Evaluate new diagnostic methods using qPCR on non-invasive samples, compared with reference techniques for the positive diagnosis of pneumocystis (PcP) in immunocompromised patients
Who can participate
Inclusion Criteria: * adult patients with suspected pneumocystis * with an indication for bronchial fibroscopy for BAL or induced sputum * no opposition to the research from the adult patient or his or her next of kin research for patients unable to express their non-opposition Exclusion Criteria: * Pneumocystis treated for more than 72 hours * pregnancy/breast-feeding * adult patients deprived of liberty, protected
Interventions
Biological sampling
OTHER
Locations 4
France (4)
Hôpital Lariboisière AP-HP Maladies infectieuses
Paris
Hôpital Saint Louis AP-HP Maladies infectieuses
Paris
Hôpital Saint Louis AP-HP Réanimation
Paris
Hôpital Saint-Louis AP-HP Pneumologie
Paris
Technical details
Status
Recruiting
Study type
OBSERVATIONAL
Sex
Male and female
Minimum age
18 Years
Healthy volunteers
No
Start date
08.07.2025
Completion date
08.07.2027
Registry ID
NCT06890078
Source
clinicaltrials.gov
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.